Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
Data Presented at the ACG Annual Meeting Demonstrates Successful Detection of Colon Entry and Topical…
News
Biora Therapeutics Shares Data from Device Performance Study in Ulcerative Colitis Patients
Data Presented at the ACG Annual Meeting Demonstrates Successful Detection of Colon Entry and Topical…
Neuronetics to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
Neuronetics to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report
Conference Call on Tuesday, November 8, 2022, at 8:30 a.m. ET Company to host “The…
Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report
Conference Call on Tuesday, November 8, 2022, at 8:30 a.m. ET Company to host “The…
Tarsus to Present Additional Saturn-2 Pivotal Phase 3 Trial Data at the American Academy of Optometry 2022 Annual Meeting
Saturn-2 follow-up data to be presented on TP-03 for the treatment of Demodex blepharitis Tarsus…
Tarsus to Present Additional Saturn-2 Pivotal Phase 3 Trial Data at the American Academy of Optometry 2022 Annual Meeting
Saturn-2 follow-up data to be presented on TP-03 for the treatment of Demodex blepharitis Tarsus…
Biopharma Veteran Ivor Macleod Joins SCYNEXIS as Chief Financial Officer
Brings deep industry experience spanning financial and operational roles to support Company and its new…
Biopharma Veteran Ivor Macleod Joins SCYNEXIS as Chief Financial Officer
Brings deep industry experience spanning financial and operational roles to support Company and its new…
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
Conference Call and Webcast to be held on November 10, 2022, at 8:30 AM ET…
Catalyst Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 9, 2022
Conference Call and Webcast to be held on November 10, 2022, at 8:30 AM ET…
Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at the 2022 ThinkEquity Conference on October 26
Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at…
Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at the 2022 ThinkEquity Conference on October 26
Immix Biopharma to Present Milestones Achieved to Enable Kick-Off of 2 IMX-110 Clinical Trials at…
Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases
Proteros selected by Adrestia for its cutting-edge structure-based drug discovery engine Proteros to support Adrestia…
Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases
Proteros selected by Adrestia for its cutting-edge structure-based drug discovery engine Proteros to support Adrestia…
Modifi Bio Receives $2.4 Million Award from National Cancer Institute to Advance Innovative Precision Oncology Platform
Yale Spinout Moves Closer Toward IND-enabling Studies NEW HAVEN, Conn., Oct. 25, 2022 (GLOBE NEWSWIRE)…
Modifi Bio Receives $2.4 Million Award from National Cancer Institute to Advance Innovative Precision Oncology Platform
Yale Spinout Moves Closer Toward IND-enabling Studies NEW HAVEN, Conn., Oct. 25, 2022 (GLOBE NEWSWIRE)…
Paratek Pharmaceuticals to Report Third-Quarter 2022 Financial Results on Nov. 3
BOSTON, Oct. 25, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that…
Paratek Pharmaceuticals to Report Third-Quarter 2022 Financial Results on Nov. 3
BOSTON, Oct. 25, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that…